Independent associations of anti-cyclic citrullinated peptide antibodies and rheumatoid factor with radiographic severity of rheumatoid arthritis

被引:90
|
作者
Mewar, Devesh
Coote, Annabel
Moore, David J.
Marinou, Ioanna
Keyworth, Jodie
Dickson, Marion C.
Montgomery, Doug S.
Binks, Michael H.
Wilson, Anthony G. [1 ]
机构
[1] Univ Sheffield, Div Genom Med, Sheffield, S Yorkshire, England
[2] GlaxoSmithKline R&D, Stevenage, Herts, England
关键词
D O I
10.1186/ar2017
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Several recent publications have established a strong association between anti-cyclic citrullinated peptide antibody (anti-CCP)-positive rheumatoid arthritis ( RA) and carriage of shared epitope ( SE) alleles. Although anti-CCP have also been associated with more severe RA, the issue of whether this is independent of rheumatoid factor (RF) has not been addressed. To identify associations between RF, anti-CCP, SE status and radiological damage, we studied a large cross- sectional cohort with longstanding RA. Individuals (n = 872) enrolled in the study all fulfilled the American College of Rheumatology criteria for RA, had a minimum disease duration of 3 years, and at least one definite radiographic erosion was present in hands or feet. Radiographs were scored blind at study entry by a single musculoskeletal radiologist using a modified Larsen's score. Anti-CCP and RF levels were determined using enzyme-linked immunosorbent assay, and DRB1 typing was performed using polymerase chain reaction based methodology. Both anti-CCP and RF levels were strongly associated with radiographic severity ( P < 0.0001). In subgroups stratified for both anti-CCP and RF status, evidence of independent associations of both antibodies with radiographic outcome was found ( P < 0.0001). An association of SE alleles with radiographic severity was present only in RF-negative individuals. Anti-CCP positivity was associated with SE status with evidence of a gene-dose effect, most markedly in RF-negative individuals ( P < 0.01). Anti-CCP and RF status are independent severity factors for RA, with SE alleles playing at most a secondary role. Our data support the view that previously described associations between SE and radiological severity, especially in RF-negative patients, may be indirect and due to an association with anti-CCP.
引用
收藏
页数:5
相关论文
共 50 条
  • [41] Reliability of Anti-Cyclic Citrullinated Peptide Antibodies (Anti-CCP) for the Diagnosis of Rheumatoid Arthritis as Compared to that of Rheumatoid Factor test
    Bolad, Ahmed
    Atea, Ayman
    Mustafa, Howeida
    Lutfi, Mohammed
    Khalafalla, Khalifa
    SUDAN JOURNAL OF MEDICAL SCIENCES, 2011, 6 (01): : 23 - 26
  • [42] A comparative evaluation of the diagnostic value of anti-cyclic citrullinated peptide and rheumatoid factor in rheumatoid arthritis
    Cho, Sun Young
    Kang, So Young
    Lee, Hee Joo
    Lee, Woo In
    KOREAN JOURNAL OF LABORATORY MEDICINE, 2008, 28 (01): : 39 - 45
  • [43] Are the anti-cyclic citrullinated peptide antibodies independent predictors of myocardial involvement in patients with active rheumatoid arthritis?
    Marasovic-Krstulovic, Daniela
    Martinovic-Kaliterna, Dusanka
    Fabijanic, Damir
    Morovic-Vergles, Jadranka
    RHEUMATOLOGY, 2011, 50 (08) : 1505 - 1512
  • [44] ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY AND RHEUMATOID FACTOR AND THE RELATIONSHIP BETWEEN PERIODONTITIS AND RHEUMATOID ARTHRITIS
    Bolyarova-Konova, Theodora Nikolaeva
    Stefanov, Lyubomir Deyanov
    Kolarov, Zlatimir Gospodinov
    Grozdanova, Radoslava Emilova
    Nikolova, Maria Hristianova
    COMPTES RENDUS DE L ACADEMIE BULGARE DES SCIENCES, 2022, 75 (03): : 451 - 457
  • [45] Regulation of anti-cyclic citrullinated peptide antibodies and rheumatoid factor by HLA DRB1 alleles in rheumatoid arthritis
    Balsa, A.
    Orozco, G.
    Pascual-Salcedo, D.
    Cobo, T.
    Miranda-Carus, M.
    Lopez-Nevot, M.
    Vicario, J. L.
    Martin, J.
    Martin-Mola, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 286 - 286
  • [46] ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODIES AND RHEUMATOID FACTOR IN SJOGREN'S SYNDROME
    Barcelos, Filipe
    Abreu, Isabel
    Patto, Jose Vaz
    Trindade, Helder
    Teixeira, Ana
    ACTA REUMATOLOGICA PORTUGUESA, 2009, 34 (04): : 608 - 612
  • [47] Effect on rheumatoid factor and anti-Cyclic Citrullinated Peptide Antibodies Levels of treatment with Infliximab and Adalimumab in patients with Rheumatoid Arthritis
    Baos, Selene
    Plasencia, Chamaida
    Ramiro, Susana
    Moral, Rosario
    Diez, Jesus
    Martin-Mola, E.
    Balsa, Alejandro
    Pascual-Salcedo, Dora
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S489 - S489
  • [48] Additional diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis
    Vallbracht, I
    Helmke, K
    AUTOIMMUNITY REVIEWS, 2005, 4 (06) : 389 - 394
  • [49] Anti-cyclic citrullinated peptide antibodies, IgM and IgA rheumatoid factors in the diagnosis and prognosis of rheumatoid arthritis
    Bas, S
    Genevay, S
    Meyer, O
    Gabay, C
    RHEUMATOLOGY, 2003, 42 (05) : 677 - 680
  • [50] Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis
    Matsui, Toshihiro
    Shimada, Kota
    Ozawa, Naoko
    Hayakawa, Hiromi
    Hagiwara, Futoshi
    Nakayama, Hisanori
    Sugii, Shoji
    Ozawa, Yoshinori
    Tohma, Shigeto
    JOURNAL OF RHEUMATOLOGY, 2006, 33 (12) : 2390 - 2397